Order Now, Ships Today
$50.00
One-time
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Quality controlled from start to finish.
No outsourcing.
PT-141, scientifically known as bremelanotide, is a synthetic peptide and melanocortin receptor agonist under investigation for its potential to address sexual dysfunction. It uniquely influences sexual arousal through central nervous system pathways rather than focusing on vascular mechanisms, distinguishing it from other treatments such as PDE5 inhibitors. PT-141 has gained approval for the management of generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, demonstrating its clinical relevance. Requires reconstitution before use.
